Filing Details

Accession Number:
0000711377-10-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-15 13:00:00
Reporting Period:
2010-04-15
Filing Date:
2010-04-15
Accepted Time:
2010-04-15 14:54:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-04-14 4,320 $8.18 113,840 No 4 M Direct
Common Stock Acquisiton 2010-04-14 5,503 $9.02 119,343 No 4 M Direct
Common Stock Disposition 2010-04-14 4,320 $25.80 115,023 No 4 S Direct
Common Stock Disposition 2010-04-14 5,503 $25.80 109,520 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option (Right-to-buy) Disposition 2010-04-14 4,320 $0.00 4,320 $8.18
Common Stock Common Stock Option (Right-to-buy) Disposition 2010-04-14 5,503 $0.00 5,503 $9.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
92,858 2010-10-31 No 4 M Direct
87,355 2011-11-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 14,012 Indirect See Footnote (1)
Footnotes
  1. Held in Company 401-K Plan
  2. The options were granted 10/31/05 and became exerciseable 20% yearly thereafter
  3. The options were granted 11/3/06 and became exerciseable 20% yearly thereafter